PGP and colorectal cancer: Similarly, Katayama et al. found that by inhibiting MEK, a component of the MAPK/ERK pathway, P-gp expression in two human colorectal cancer cells, HCT-15 and SW620, was reduced between 5- and 20-fold compared to untreated cells [118].